Trial intelligence / Profile preview

Rabeprazole for Prevention of Post-EMR Ulcer Bleeding

NCT00844675Phase 4Completed

Sponsor
The Catholic University of Korea
Start
Oct 2007
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rabeprazole in gastric adenoma, gastric adenocarcinoma, sponsored by The Catholic University of Korea. Started Oct 2007; status: completed.

02

Drugs

rabeprazole
03

Conditions

gastric adenomagastric adenocarcinoma

Beyond the preview

Go deeper on NCT00844675.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00844675.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call